Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study

BACKGROUND: In randomized, controlled trials of open-angle glaucoma (OAG) or ocular hypertension (OHT), bimatoprost 0.01 % improved tolerability while retaining the intraocular pressure (IOP)-lowering efficacy of bimatoprost 0.03 %. Given geographic/racial differences in glaucoma presentation, the A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying Ying, Wang, Tsing-Hong, Liu, Catherine, Wu, Kwou-Yeung, Chiu, Shin-Lin, Simonyi, Susan, Lu, Da-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025541/
https://www.ncbi.nlm.nih.gov/pubmed/27633513
http://dx.doi.org/10.1186/s12886-016-0338-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025541/
https://www.ncbi.nlm.nih.gov/pubmed/27633513
http://dx.doi.org/10.1186/s12886-016-0338-6

Ejemplares similares